Halo Neuroscience

company

About

Halo Neuroscience is a neurotech company focused on using electrical neurostimulation to unlock human performance and treat human disease

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$13M
Industries
Consumer Electronics,Health Care,Medical Device,Neuroscience,Sports
Founded date
Jan 1, 2013
Number Of Employee
11 - 50
Operating Status
Active

Halo Neuroscience develops and markets neurotechnology systems to help individuals unlock their true potential. Their first product, Halo Sport, utilizes Neuropriming technology to accelerate skill and strength acquisition in elite athletes.

Neuropriming is the process of using electrical stimulation during movement-based training to build stronger, more optimized connections between your brain and muscles. This process induces a temporary state of hyper-learning or "hyperplasticity" in the brain, which refines the brain's ability to learn and adapt to training.

The company was incorporated in 2013 and is based in San Francisco, CA.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$13M
Halo Neuroscience has raised a total of $13M in funding over 2 rounds. Their latest funding was raised on Jan 30, 2018 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 30, 2018 Series B $13M 1 TPG Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Halo Neuroscience is funded by 1 investors. TPG are the most recent investors.
Investor Name Lead Investor Funding Round
TPG Yes Series B